Cencora, Inc. (New York Stock Exchange:COR)
| Market Cap | 62.91B+9.1% |
| Revenue (ttm) | 332.77B+5.1% |
| Net Income | 2.62B+38.3% |
| EPS | 13.46+38.5% |
| Shares Out | 194.56M |
| PE Ratio | 23.91 |
| Forward PE | 16.32 |
| Dividend | $2.40(0.74%) |
| Ex-Dividend Date | Aug 14, 2026 |
| Volume | 1,040,979 |
| Open | 322.24 |
| Previous Close | 324.69 |
| Day's Range | 321.92 - 326.96 |
| 52-Week Range | 244.82 - 377.54 |
| Beta | 0.57 |
| Analysts | Buy |
| Price Target | 358.14(+10.77%) |
| Earnings Date | Nov 4, 2026 |
About COR
Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting. It develops and implements supply management software, provides packaging services for both institutional and retail healthcare settings, and assists with clinical trial support, post-market approval processes, and commercialization strategies. For biotechnology and pharmaceutical manufacturers, the company delivers data analytics, outcomes research, and other specialized services. Furthermore, Cencora serves the animal health market, providing pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients for both companion and production animals. It also offers sales force support to manufacturers and specialized services to medical professionals, particularly oncologists, as well as to hospitals and dialysis clinics. The International Healthcare Solutions division concentrates on global pharmaceutical wholesale activities, associated services, and worldwide commercialization support. It ensures the efficient distribution of medicines, various healthcare goods, and related services to an international customer base comprising pharmacies, doctors, health centers, and hospitals. This segment also delivers specialized transportation and logistics solutions specifically designed for the biopharmaceutical sector. Founded in 1871, the company was formerly known as AmerisourceBergen Corporation before adopting the name Cencora, Inc. in August 2023. Its corporate headquarters are situated in Conshohocken, Pennsylvania.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$COR stock is featured in our Insider Score Rankings, Congress Trading, and Insider Trades datasets.
→ All Stock ListsCongress Trading
Recent trades of COR by members of U.S. Congress
| Politician | Type | Traded |
|---|---|---|
| Jared MoskowitzHouse / D | Sale$1.00K – $15.00K | May 5, 2026 |
| Jared MoskowitzHouse / D | Purchase$1.00K – $15.00K | Mar 30, 2026 |
| Jared MoskowitzHouse / D | Purchase$1.00K – $15.00K | Mar 22, 2026 |
Recently reported changes in COR holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by COR's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
COR Estimated quarterly lobbying spending
Source: U.S. Senate LDA
COR Revenue by Segment or Geography
Source: SEC EDGAR (10-Q/10-K)
U.S. Patents
New COR patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to COR from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in COR
| ETF | Est. Holding Size |
|---|---|
| VTIVanguard Morningstar Total Stock Market ETF | $1.83B |
| VOOVanguard S&P 500 ETF | $1.59B |
| VOVanguard Morningstar Mid-Cap ETF | $1.25B |
| IVViShares Core S&P 500 ETF | $857.94M |
| SPYState Street SPDR S&P 500 ETF | $776.43M |
| VTVVanguard Morningstar Value ETF | $548.09M |
Estimated from each fund’s disclosed top holdings × AUM
COR Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from COR’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score